DIA 2017 Editor’s Take – Celerion

Thought Leader:

Staci McDonald PharmD, Executive Director, Scientific Clinical Operations, Celerion

July 26, 2017      

Staci McDonald, PharmD discusses how Celerion’s business is changing with the emergence of biosimilar drugs, why biosimilar developers choose to work with Celerion, and what they have learned in the course of their biosimilar research.

For more information please visit www.celerion.com.

Post a Comment

You must be logged in to post a Comment.